Provenienza dei contatti di primo grado di Danny Joh
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Danny Joh tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| Royal Institute of Technology | College/University | Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Corporate Officer/Principal | |
| Universität des Saarlandes | College/University | Doctorate Degree | |
Eleva GmbH
 Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany. | Biotechnology | Chief Executive Officer | |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman | |
| GENSCRIPT BIOTECH CORPORATION | Biotechnology | Corporate Officer/Principal | |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Corporate Officer/Principal | |
Sapreme Technologies BV
 Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Biotechnology | Chairman | |
| Neurocode Labs, Inc. | Chief Tech/Sci/R&D Officer | ||
Ciliatech Therapeutics AG
 Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Ciliatech Therapeutics AG is a Swiss company that focuses on researching, developing, producing, and distributing pharmaceutical and diagnostic products. | Pharmaceuticals: Major | Chief Executive Officer | |
| Medraxa Therapeutics GmbH | Chief Executive Officer | ||
| BC Biomed Consulting GmbH | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Germania | 7 |
| Svezia | 4 |
| Svizzera | 3 |
| Stati Uniti | 2 |
| Norvegia | 2 |
Settori
| Health Technology | 9 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Finance | 2 |
Posizioni
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Björn Cochlovius | 15 |
| Hans Frykman | 4 |
| Berkan Unal | 2 |
- Borsa valori
- Insiders
- Danny Joh
- Connessioni Società
